Clinical Trial Update: The Efficacy and Safety of Edaravone Dexborneol Sequential Therapy in the Treatment of Patients With AIS [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of edaravone dexborneol sequential therapy in patients with acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• edaravone dexborneol sequential therapy (edaravone dexborneol sequential therapy)

Snippet

Sponsor: Simcere Pharmaceutical Co., Ltd | Conditions: Subjects With Acute Ischemic Stroke | Phase 3 | Status: UNKNOWN